Abstract

Administered in vivo, covalent receptor-recognized α2-macroglobulin (α2M*)-antigen complexes enhance humoral and cell-mediated immunity. We hypothesized that in vivo α2M*-encapsulation could be promoted in the setting of vaccines that co-deliver α2M* with unbound antigen, thereby eliminating the need to prepare complexes in vitro. Mice immunized intradermally with co-delivered α2M* and OVA demonstrated antigen-specific immune responses, including anti-tumor responses, similar to those elicited by conjugated α2M*-OVA complexes. Enhanced immunity appears to result from in vivo α2M*-encapsulation of antigen. This finding represents a significant advancement in the development of α2M* as an antigen delivery vehicle capable of enhancing the presentation of subunit vaccines.

Highlights

  • Previous studies have demonstrated that antigen encapsulation by α2-macroglobulin (α2M)1 enhances antigen-specific immune responses, both in vitro and in vivo [1,2,3,4,5,6,7]

  • Α2M-encapsulated antigen complexes were typically prepared by in vitro incubation of amine-activated α2M, designated α2M*, with an 8 to 100-fold-molar excess of antigen in the presence of heat [3,4,7]. These α2M*-antigen complexes were purified by size-exclusion chromatography to remove unbound antigen

  • We investigate the ability of α2M*, co-administered with unbound antigen, to enhance antigen-specific immune responses through in vivo encapsulation, resulting in enhanced antigen delivery

Read more

Summary

Introduction

Previous studies have demonstrated that antigen encapsulation by α2-macroglobulin (α2M) enhances antigen-specific immune responses, both in vitro and in vivo [1,2,3,4,5,6,7]. For these studies, α2M-encapsulated antigen complexes were typically prepared by in vitro incubation of amine-activated α2M, designated α2M*, with an 8 to 100-fold-molar excess of antigen in the presence of heat [3,4,7]. We investigate the ability of α2M*, co-administered with unbound antigen, to enhance antigen-specific immune responses through in vivo encapsulation, resulting in enhanced antigen delivery

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.